Factors Associated With Poor Response to Aflibercept After Switching From Ranibizumab or Bevacizumab in Neovascular Age-related Macular Degeneration.
Ophthalmic Surg Lasers Imaging Retina
; 47(5): 458-65, 2016 05 01.
Article
in En
| MEDLINE
| ID: mdl-27183550
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Receptors, Vascular Endothelial Growth Factor
/
Wet Macular Degeneration
/
Drug Substitution
/
Bevacizumab
/
Ranibizumab
/
Macula Lutea
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged80
/
Female
/
Humans
/
Male
Language:
En
Journal:
Ophthalmic Surg Lasers Imaging Retina
Year:
2016
Document type:
Article